BRPI0812771A2 - Método para a detecção e diagnóstico in vitro de uma infecção por um microorganismo, conjunto de reagentes para a realização do método de detecção . - Google Patents

Método para a detecção e diagnóstico in vitro de uma infecção por um microorganismo, conjunto de reagentes para a realização do método de detecção .

Info

Publication number
BRPI0812771A2
BRPI0812771A2 BRPI0812771-9A2A BRPI0812771A BRPI0812771A2 BR PI0812771 A2 BRPI0812771 A2 BR PI0812771A2 BR PI0812771 A BRPI0812771 A BR PI0812771A BR PI0812771 A2 BRPI0812771 A2 BR PI0812771A2
Authority
BR
Brazil
Prior art keywords
detection
microorganism
reagents
infection
carrying
Prior art date
Application number
BRPI0812771-9A2A
Other languages
English (en)
Inventor
Christine Charpentier
Stephane Gadelle
Nadine Lambert
Amparo Sanjuan
Original Assignee
Bio Rad Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Rad Pasteur filed Critical Bio Rad Pasteur
Publication of BRPI0812771A2 publication Critical patent/BRPI0812771A2/pt
Publication of BRPI0812771B1 publication Critical patent/BRPI0812771B1/pt
Publication of BRPI0812771B8 publication Critical patent/BRPI0812771B8/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326—Magnetic particles
    • G01N33/54333—Modification of conditions of immunological binding reaction, e.g. use of more than one type of particle, use of chemical agents to improve binding, choice of incubation time or application of magnetic field during binding reaction
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/01—DNA viruses
    • G01N2333/02—Hepadnaviridae, e.g. hepatitis B virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/085—Picornaviridae, e.g. coxsackie virus, echovirus, enterovirus
    • G01N2333/10—Hepatitis A virus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
BRPI0812771A 2007-06-08 2008-06-06 método para a detecção e diagnóstico in vitro de uma infecção por um microorganismo BRPI0812771B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0755626A FR2917173B1 (fr) 2007-06-08 2007-06-08 Procede multiplexe de detection d'une infection
US92906107P 2007-06-11 2007-06-11
PCT/EP2008/057111 WO2008148883A1 (en) 2007-06-08 2008-06-06 Multiplex method for detecting an infection

Publications (3)

Publication Number Publication Date
BRPI0812771A2 true BRPI0812771A2 (pt) 2014-12-02
BRPI0812771B1 BRPI0812771B1 (pt) 2019-01-22
BRPI0812771B8 BRPI0812771B8 (pt) 2021-07-27

Family

ID=38457970

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0812771A BRPI0812771B8 (pt) 2007-06-08 2008-06-06 método para a detecção e diagnóstico in vitro de uma infecção por um microorganismo

Country Status (9)

Country Link
US (2) US20100151445A1 (pt)
EP (1) EP2160605B1 (pt)
JP (1) JP5216852B2 (pt)
CN (1) CN101711361B (pt)
BR (1) BRPI0812771B8 (pt)
CA (1) CA2687827C (pt)
EA (1) EA017206B1 (pt)
FR (1) FR2917173B1 (pt)
WO (1) WO2008148883A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103635591A (zh) * 2011-01-26 2014-03-12 布里格姆及妇女医院股份有限公司 由免疫复合物直接对微生物进行测序的测定法与方法
US10732178B2 (en) * 2013-01-29 2020-08-04 Bio-Rad Haifa Ltd. Detection assays employing magnetic nanoparticles
CN105358977A (zh) * 2013-04-26 2016-02-24 生物辐射实验室股份有限公司 多重乙肝试验
CN104714028B (zh) * 2015-03-02 2017-01-25 深圳市凯瑞德生物技术有限公司 一种检测IgM抗体的免疫检测方法
CN107533060B (zh) * 2015-03-10 2019-11-05 生物辐射实验室股份有限公司 组合密螺旋体和非密螺旋体梅毒测试
EP3359558B1 (en) 2015-10-06 2023-12-13 Bio-Rad Laboratories, Inc. Borrelia immunoassays and materials therefor
CN108351351B (zh) 2015-11-09 2021-10-29 生物辐射实验室股份有限公司 使用亲和素和生物素的试验
JP6918808B2 (ja) * 2016-08-31 2021-08-11 栄研化学株式会社 異なる方式で抗原を固定化した抗原担持不溶性担体粒子を用いる抗体測定法、抗体測定用試薬
JP7128196B2 (ja) * 2017-03-01 2022-08-30 エフ．ホフマン－ラ ロシュ アーゲー 検体の存在に関する生体サンプルの分類のためのシステムおよび方法
CA3107883A1 (en) * 2018-07-27 2020-01-30 Veravas, Inc. Method for detecting biomarkers
EP4016080A4 (en) * 2019-08-16 2023-01-11 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. ALL NEW IMMUNOASSAY MODE FOR DETERMINING TOTAL ANTIBODIES
WO2021203044A2 (en) * 2020-04-03 2021-10-07 Icahn School Of Medicine At Mount Sinai High-throughput assay for circulating antibodies against severe acute respiratory syndrome coronavirus 2
CN115397465B (zh) * 2020-04-24 2026-04-24 美国西门子医学诊断股份有限公司 用于针对抗体的免疫测定的校准和质量控制试剂
WO2022263644A1 (en) * 2021-06-17 2022-12-22 Roche Diagnostics Gmbh Thermostable affinity polypeptides

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1172561A (en) 1981-01-28 1984-08-14 Richard H. Decker Igm detection method
EP0189389B1 (fr) * 1985-01-24 1989-04-05 Institut International De Pathologie Cellulaire Et Moleculaire Procédé de dosage immunologique d'anticorps de diverses classes dans un échantillon liquide
JPS6270764A (ja) * 1985-03-08 1987-04-01 Sanko Junyaku Kk 血清中の免疫抗体測定方法
JPS6488369A (en) * 1987-08-14 1989-04-03 Ortho Diagnostic Systems Inc Method of detecting and verifying presence of antibody
JPH05133952A (ja) * 1991-04-03 1993-05-28 Syntex Usa Inc イムノグロブリン類のイムノアツセイ
CA2064972A1 (en) * 1991-04-03 1992-10-04 John Joseph Rejman Immunoassay for immunoglobulins
EP0965044B1 (en) * 1997-11-18 2003-03-19 Bio-Rad Laboratories, Inc. Multiplex flow immunoassays with magnetic particles as solid phase
ITTO980473A1 (it) * 1998-06-02 1999-12-02 Sorin Diagnostics S R L Nuovo procedimento per la rivelazione di anticorpi e/o isotipi di anticorpi specifici per almeno due differenti fasi di un'infezione
WO2001073443A2 (en) * 2000-03-28 2001-10-04 The Government Of The United State Of America, As Represented By The Secretary Of The Department Of Health And Human Services Methods and compositions for the simultaneous detection of multiple analytes
JP2002310875A (ja) * 2001-04-16 2002-10-23 National Institute Of Advanced Industrial & Technology 梅毒検査試薬及び梅毒検査方法
WO2003093511A1 (en) * 2002-04-30 2003-11-13 Merck & Co., Inc. Human papillomavirus multiplexed assay
FR2839555B1 (fr) * 2002-05-10 2007-07-27 Bio Rad Pasteur Procede de detection simultanee d'un antigene et d'un anticorps d'un microorganisme infectieux
CN1164948C (zh) * 2002-06-06 2004-09-01 成都夸常科技有限公司 一种基于抗原抗体反应的试剂盒
US20070298432A1 (en) * 2003-11-07 2007-12-27 Hep-Genics Pty Ltd Binding Assay Components

Also Published As

Publication number Publication date
EP2160605B1 (en) 2017-11-01
EA017206B1 (ru) 2012-10-30
JP2010529443A (ja) 2010-08-26
CA2687827C (en) 2017-08-29
CA2687827A1 (en) 2008-12-11
BRPI0812771B8 (pt) 2021-07-27
WO2008148883A1 (en) 2008-12-11
US9523685B2 (en) 2016-12-20
CN101711361A (zh) 2010-05-19
US20100151445A1 (en) 2010-06-17
EP2160605A1 (en) 2010-03-10
FR2917173A1 (fr) 2008-12-12
JP5216852B2 (ja) 2013-06-19
US20130273525A1 (en) 2013-10-17
FR2917173B1 (fr) 2009-07-31
EA200971123A1 (ru) 2010-06-30
BRPI0812771B1 (pt) 2019-01-22
CN101711361B (zh) 2016-08-31

Similar Documents

Publication Publication Date Title
BRPI0816429A2 (pt) microorganismo, e, método para a produção de um l-aminoácido.
FR2903992B1 (fr) Composition de scintillateur, article et procede associe.
BRPI0815494A2 (pt) Método implementado por computador, e, sistema.
BRPI0917120A2 (pt) método, e, meio legível por computador.
BRPI0905853A2 (pt) Meios de fermentação e processos destes.
BRPI0823030A2 (pt) Sistema de elevador, e, método para fazer um sistema de elevador.
BRPI0819876A2 (pt) Sistema de enumeração e método para exibição de led.
BR112012014414A2 (pt) "método, sistema e meio legível por máquina codificado com instruções, para adaptar um fluxo de trabalho médico"
BRPI0814939A2 (pt) Entidade química, composição farmacêutica, e, método para tratar uma infecção viral em um mamífero.
BRPI0819517A2 (pt) "método para detectar a presença de um microorganismo alvo em uma amostra"
BRPI0817477A2 (pt) Método computadorizado, meio legível por máquina, aparelho, e, sistema computadorizado.
BRPI0822078A2 (pt) Método, e, sistema.
BRPI0813914A2 (pt) Sistema, e, método.
BRPI1016158A2 (pt) "sistema e método para monitorar um desempenho atlético, e, sistema e método de monitoramento do desempenho atlético."
BRPI0812770A2 (pt) Método in vitro para identificar uma pluralidade de moléculas antigênicas transportadas por eritrócitos de um indivíduo, e/ou identificar uma pluralidade de anticorpos contra moléculas antigênicas transportadas por eritrócitos, conjunto de reagentes para implementar o método de detecção .
BRPI0822756A2 (pt) sistema de prótese de válvula cardíaca e processo para produzir prótese de válvula cardíaca.
BRPI0813757A2 (pt) Sistema de implante, e, método
BRPI1008634A2 (pt) "um meio de conexão, um método de fabricação do mesmo e uma conexão de material".
BRPI1015558A2 (pt) chip biológico microfluídico, e, método de usar o mesmo.
BRPI0906892A2 (pt) "método para a obtenção de um produto em um bioreator, sistema para a obtenção de um produto que compreende um bioreator, bioreator, bioreator para a fermentação de um produto biológico no suporte sólido e método para a obtenção de um produto biológico"
BRPI0922312A2 (pt) método, e, meio legível por computador
BRPI0820122A2 (pt) Método de otimização de produção de poços, sistema, e método.
BRPI1013896A2 (pt) Célula de levedura, e, métodos para produzir um composto isoprenóide e para detectar em uma amostra biológica a presença ou ausência de uma célula microbiana geneticamente.
BRPI0906086A2 (pt) Método, sistemas e meio legível por computador.
BRPI0921757A2 (pt) indicador de posição de válvula, método para determinar uma posição de uma válvula, e , sistema indicador de posição de válvula.

Legal Events

Date Code Title Description
B25F Entry of change of name and/or headquarter and transfer of application, patent and certif. of addition of invention: change of name on requirement

Owner name: BIO-RAD PASTEUR (FR)

Free format text: A FIM DE ATENDER A ALTERACAO DE NOME REQUERIDA ATRAVES DA PETICAO NO 20120003316/RJ, DE 13/01/2012, E NECESSARIO APRESENTAR O DOCUMENTO DEVIDAMENTE NOTARIZADO.

B25D Requested change of name of applicant approved

Owner name: BIO-RAD INNOVATIONS (FR)

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 22/01/2019, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 06/06/2008, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO

B25A Requested transfer of rights approved

Owner name: BIO-RAD FRANCE HOLDING (FR)

B25A Requested transfer of rights approved

Owner name: BIO-RAD EUROPE GMBH (CH)

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 17A ANUIDADE.

B24G Patent annual fee: republication

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 2830 DE 01/04/2025, ITEM 21.6, POR NAO TER SIDO DISPONIBILIZADO O PARECER PARA CONSULTA DO TITULAR.